Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation

Sanara MedTech Inc. (WNDM) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/16/2023 8-K Regulation FD Disclosure  Interactive Data
08/14/2023 8-K Investor presentation, Quarterly results
Docs: "SANARA MEDTECH INC. AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS June 30, December 31, 2023 2022 Assets Current assets Cash $ 6,060,228 $ 8,958,995 Accounts receivable, net 7,141,105 6,805,761 Accounts receivable – related party 20,662 98,548 Royalty receivable 49,344 99,594 Inventory, net 4,420,864 3,549,000 Prepaid and other assets 485,734 1,104,611 Total current assets 18,177,937 20,616,509 Long-term assets Property and equipment, net 1,240,269 1,416,436 Right of use assets – operating leases 2,030,938 806,402 Goodwill 3,601,781 3,601,781 Intangible assets, net 30,143,578 31,509,980 Investment in equity securities 3,084,278 3,084,278 Total long-term assets 40,100,844 40,418,877 Total assets $ 58,278,781 $ 61,035,386 Liabilities and shareholders’ equity Current liabilities Accounts payab..."
08/02/2023 8-K Quarterly results
06/06/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
03/20/2023 8-K Quarterly results
02/24/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "Sales Agreement",
"Fort Worth, TX 76102",
"CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 , and the Prospectus Supplement constituting a part of this Registration Statement of our report dated March 30, 2022, relating to the consolidated financial statements of Sanara MedTech Inc. and its subsidiaries appearing in the entity’ s Annual Report on Form 10-K for the year ended December 31, 2021. We also consent to the reference to us under the caption “Experts” in the Prospectus Supplement."
02/22/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Investor Contact:"
12/16/2022 8-K Quarterly results
12/06/2022 8-K Quarterly results
11/30/2022 8-K Quarterly results
11/15/2022 8-K/A Quarterly results
11/14/2022 8-K Quarterly results
08/15/2022 8-K Quarterly results
07/15/2022 8-K/A Quarterly results
07/05/2022 8-K Quarterly results
06/10/2022 8-K Quarterly results
05/16/2022 8-K Quarterly results
04/29/2022 8-K Quarterly results
04/08/2022 8-K Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity ...
Docs: "SANARA MEDTECH INC. COMMON STOCK WARRANT Original Issue Date: April 4, 2022 Void After: 5 PM Eastern Time on April 22, 2031 This Warrant Is Issued to Furneaux Capital Holdco, LLC by Sanara MedTech Inc., a Texas corporation . The Company hereby certifies as of the Original Issue Date that, for value received, the Holder is entitled, subject to the terms and conditions set forth in this Warrant, to purchase from the Company, at any time on or after the Original Issue Date and in any event not after the Expiration Date , 4,424 duly authorized, validly issued, fully paid, nonassessable shares of the Company’ s Common Stock, par value $0.001 per share , at an initial purchase price per share equal to $7.32 per share. The number of shares of Common Stock and the purchase price thereof shall be ...",
"SANARA MEDTECH INC. COMMON STOCK WARRANT Original Issue Date: April 4, 2022 Void After: 5 PM Eastern Time on August 10, 2030 This Warrant Is Issued to Furneaux Capital Holdco, LLC by Sanara MedTech Inc., a Texas corporation . The Company hereby certifies as of the Original Issue Date that, for value received, the Holder is entitled, subject to the terms and conditions set forth in this Warrant, to purchase from the Company, at any time on or after the Original Issue Date and in any event not after the Expiration Date , 12,301 duly authorized, validly issued, fully paid, nonassessable shares of the Company’ s Common Stock, par value $0.001 per share , at an initial purchase price per share equal to $12.05 per share. The number of shares of Common Stock and the purchase price thereof shall ...",
"Plan”). The purpose of the Plan is to encourage and enable the officers, employees, directors, Consultants and other key Persons of Precision Healing Inc., a Delaware corporation and its Subsidiaries, upon whose judgment, initiative and efforts the Company largely depends for the successful conduct of its business, to acquire a proprietary interest in the Company.",
"Investor Contact:"
04/04/2022 8-K Acquisition/merger/asset purchase announced
Docs: "AGREEMENT AND PLAN OF MERGER BY AND AMONG PRECISION HEALING INC., United Wound and Skin Solutions, LLC, Sanara Medtech Inc., PH MERGER SUB I, INC., PH MERGER SUB II, LLC, AND FURNEAUX CAPITAL HOLDCO, LLC AS THE SECURITYHOLDERS’ REPRESENTATIVE DATED AS OF APRIL 1, 2022",
"Investor Contact:"
03/30/2022 8-K Investor presentation
Docs: "Investor Contact:"
03/28/2022 8-K Termination of a Material Definitive Agreement, Shareholder Nominations Pursuant to Exchange Act Rule 14a-11, Other Events ...
02/22/2022 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Investor Contact:"
01/06/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
12/28/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "FORT WORTH, TX / December 28, 2021 / Sanara MedTech Inc. , a provider of products and technologies for surgical and chronic wound care dedicated to improving patient outcomes, announced today that Zachary B. Fleming has been appointed Chief Executive Officer effective January 1, 2022."
12/22/2021 8-K Appointed a new director
Docs: "RETIREMENT AGREEMENT",
"Investor Contact:"
12/15/2021 8-K Quarterly results
11/15/2021 8-K Investor presentation, Quarterly results
Docs: "Sanara MedTech Inc. Announces Third Quarter 2021 Results and Business Update FORT WORTH, TX / ACCESSWIRE / November 12, 2021 / Sanara MedTech Inc",
"Investor Presentation (furnished pursuant to Item 2.02)"
09/30/2021 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
09/23/2021 8-K Quarterly results
09/13/2021 8-K Quarterly results
08/16/2021 8-K Quarterly results
08/06/2021 8-K Shareholder Nominations Pursuant to Exchange Act Rule 14a-11, Other Events
07/19/2021 8-K Entered into consulting agreement
Docs: "Asset Purchase Agreement, by and between Sanara MedTech Inc., as Purchaser, and Rochal Industries, LLC, as Seller",
"Consulting Agreement, by and between Sanara MedTech Inc. and Ann Beal Salamone",
"Sanara MedTech Inc. Announces the Purchase of Certain Assets from Rochal Industries, LLC FORT WORTH, TX / ACCESSWIRE / July 19, 2021 / Sanara MedTech Inc."
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy